CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Outpatient Control-to-Rangedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01578980
NCT01578980N/ACompleted
CompareCT.gov

Outpatient Control-to-Range: System and Monitoring Testing

University of Virginia·interventional·Posted Apr 17, 2012·Updated Sep 16, 2014

In Brief

A clinical study evaluating Outpatient Control-to-Range for Type 1 Diabetes Mellitus. Completed, enrolled 20 participants across 2 sites.

Detailed Summary

A single arm, single treatment study is proposed to assess the feasibility of the AP Platform (cell phone + Control to Range system) outside of a hospital based clinical research center.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus
CountriesUnited States
CollaboratorsJuvenile Diabetes Research Foundation, University of California, Santa Barbara

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 17, 2012
Enrollment StartApr 1, 2012
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 14.2 years ago

Interventions

Outpatient Control-to-Rangedevice

Subjects will spend two nights (\~42 hours) in a local hotel during which the AP Platform will be remotely monitored in an adjacent hotel room for validation that remote system monitoring can successfully occur.